Special-purpose acquisition company

Scinai Immunotherapeutics Regains Compliance with Nasdaq's Stockholders' Equity Rule

Retrieved on: 
Monday, November 20, 2023

JERUSALEM, Nov. 20, 2023 /PRNewswire/ -- Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI) today announced today the receipt of formal notification from the Nasdaq Stock Market ("Nasdaq") that the Company has regained compliance with Nasdaq listing rules regarding minimum stockholders' equity.

Key Points: 
  • JERUSALEM, Nov. 20, 2023 /PRNewswire/ -- Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI) today announced today the receipt of formal notification from the Nasdaq Stock Market ("Nasdaq") that the Company has regained compliance with Nasdaq listing rules regarding minimum stockholders' equity.
  • Nasdaq indicated that their determination that the Company complies with Listing Rule 5550(b)(1), which requires listed companies to maintain a minimum $2.5 million in stockholders' equity, is based on the content of the Company's Form 6-K dated November 13, 2023.
  • This change impacted the classification of most of the current and future warrants as equity and not as liabilities, as per GAAP accounting rules.
  • The Company expects this new WACC to be incorporated in the Company's financial statements for the year ending December 31, 2023.

SenesTech Announces Reverse Stock Split

Retrieved on: 
Wednesday, November 15, 2023

PHOENIX, Nov. 15, 2023 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company") (www.senestech.com), the leader in fertility control to manage animal pest populations, today announced that it intends to effect a reverse stock split of its common stock at a ratio of 1 post-split share for every 12 pre-split shares. The reverse stock split will become effective at 4:01 p.m, Eastern Time, on November 16, 2023. The Company's common stock will continue to be traded on the Nasdaq Capital Market under the symbol "SNES" and will begin trading on a split-adjusted basis when the market opens on November 17, 2023.

Key Points: 
  • At the effective time of the reverse stock split, every 12 shares of the Company's issued common stock will be converted automatically into one issued share of common stock without any change in the par value per share.
  • It is not necessary for stockholders holding shares of the Company's common stock in certificated form to exchange their existing stock certificates for new stock certificates of the Company in connection with the reverse stock split, although stockholders may do so if they wish.
  • The reverse stock split will affect all stockholders uniformly and will not alter any stockholder's percentage interest in the Company's equity, except to the extent that the reverse stock split would result in a stockholder owning a fractional share.
  • The reverse stock split will reduce the number of issued shares of the Company's common stock from 5,899,060 shares to approximately 491,589 shares.

MDxHealth Announces the Approval by its Shareholders of the Proposed Transition to a Sole Listing of Shares on Nasdaq, and Details of the Share Consolidation

Retrieved on: 
Monday, November 6, 2023

As a result, the Company can now start implementing the Transaction and Share Consolidation, as further outlined below.

Key Points: 
  • As a result, the Company can now start implementing the Transaction and Share Consolidation, as further outlined below.
  • The implementation of the Transaction was still subject to the approval by the Company's shareholders of the Share Consolidation and the De-Listing.
  • The Share Consolidation will be carried out simultaneously for all outstanding Shares, so that after the completion of the Share Consolidation each new Share will represent the same fraction of the Company's share capital.
  • The Share Consolidation will be implemented automatically, without the need for shareholders to take any steps whatsoever.

HLLY SHAREHOLDER ALERT: Johnson Fistel Investigates Holley Inc. f/k/a Empower Ltd.

Retrieved on: 
Tuesday, October 31, 2023

SAN DIEGO, Oct. 31, 2023 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP ( www.JohnsonFistel.com ) is investigating whether Holley Inc. f/k/a Empower Ltd. (NYSE: HLLY), any of its executive officers or others violated securities laws by misrepresenting or failing to timely disclose material, adverse information to investors.

Key Points: 
  • SAN DIEGO, Oct. 31, 2023 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP ( www.JohnsonFistel.com ) is investigating whether Holley Inc. f/k/a Empower Ltd. (NYSE: HLLY), any of its executive officers or others violated securities laws by misrepresenting or failing to timely disclose material, adverse information to investors.
  • What if I purchased Holley securities?
  • If you purchased Holley securities and suffered significant losses on your investment, join our investigation now:
    There is no cost or obligation to you.
  • On July 16, 2021, Empower Ltd., a SPAC (Special Purpose Acquisition Company), and Holley Intermediate Holdings, Inc. completed a business combination in which the company began trading on the NYSE under the name Holley Inc.

Investors Title Company Board Declares Special Cash Dividend and Regular Quarterly Cash Dividend

Retrieved on: 
Monday, November 6, 2023

Investors Title Company (Nasdaq: ITIC) announced today that the Company's Board of Directors declared a special cash dividend of $4.00 per share to shareholders of record on December 1, 2023, payable December 15, 2023.

Key Points: 
  • Investors Title Company (Nasdaq: ITIC) announced today that the Company's Board of Directors declared a special cash dividend of $4.00 per share to shareholders of record on December 1, 2023, payable December 15, 2023.
  • The Board also declared a regular quarterly cash dividend of $.46 per share to shareholders of record December 1, 2023, payable on December 15, 2023.
  • Investors Title Company is a publicly held North Carolina company whose stock is traded on The Nasdaq Global Select Market.
  • Investors Title Company is engaged in the business of issuing and underwriting title insurance policies.

AVANTI HELIUM ANNOUNCES THE PRICING OF OVERNIGHT MARKETED BEST EFFORTS PUBLIC OFFERING OF UNITS

Retrieved on: 
Friday, November 3, 2023

CALGARY, AB, Nov. 3, 2023 /CNW/ - Avanti Helium Corp. (TSXV: AVN) (OTC: ARGYF) ("Avanti" or the "Company"), is pleased to announce the pricing of the previously announced, on November 2, 2023, overnight marketed best efforts public offering (the "Offering") of units of the Company ("Units").

Key Points: 
  • CALGARY, AB, Nov. 3, 2023 /CNW/ - Avanti Helium Corp. (TSXV: AVN) (OTC: ARGYF) ("Avanti" or the "Company"), is pleased to announce the pricing of the previously announced, on November 2, 2023, overnight marketed best efforts public offering (the "Offering") of units of the Company ("Units").
  • Pursuant to the Offering, which is being conducted on a "best efforts" agency basis, Avanti will issue 6,667,000 Units at a price of $0.45 per Unit for aggregate gross proceeds of up to $3,000,150.
  • Each Warrant will entitle the holder to acquire one Common Share for 24 months from the closing of the Offering at an exercise price of $0.60.
  • The Offering will be conducted pursuant to the Company's Canadian base shelf prospectus dated November 23, 2022 (the "Base Shelf Prospectus").

AVANTI HELIUM ANNOUNCES OVERNIGHT MARKETED BEST EFFORTS PUBLIC OFFERING OF UNITS

Retrieved on: 
Thursday, November 2, 2023

CALGARY, AB, Nov. 2, 2023 /CNW/ - Avanti Helium Corp. (TSXV: AVN) (OTC: ARGYF) ("Avanti" or the "Company"), is pleased to announce that it has commenced an overnight marketed best efforts public offering (the "Offering") of units (the "Units") of the Company, seeking to raise gross proceeds of approximately $3 million.

Key Points: 
  • CALGARY, AB, Nov. 2, 2023 /CNW/ - Avanti Helium Corp. (TSXV: AVN) (OTC: ARGYF) ("Avanti" or the "Company"), is pleased to announce that it has commenced an overnight marketed best efforts public offering (the "Offering") of units (the "Units") of the Company, seeking to raise gross proceeds of approximately $3 million.
  • Each Unit will be comprised of one common share of the Company and one-half of one common share purchase warrant (a "Warrant").
  • The Offering will be conducted pursuant to the Company's Canadian base shelf prospectus dated November 23, 2022 (the "Base Shelf Prospectus").
  • A prospectus supplement (the "Prospectus Supplement") relating to the Offering will be filed in each of the provinces of Canada, except the Province of Quebec.

Holley, Inc. SHAREHOLDER ALERT: Johnson Fistel Encourages Holley Inc. f/k/a Empower Ltd. Shareholders with Losses to Contact the Firm Regarding Investigation

Retrieved on: 
Tuesday, October 24, 2023

The investigation focuses on investors’ losses and whether they may be recovered under federal securities laws.

Key Points: 
  • The investigation focuses on investors’ losses and whether they may be recovered under federal securities laws.
  • If you purchased Holley securities and suffered significant losses on your investment, join our investigation now:
    There is no cost or obligation to you.
  • The investigation pertains to whether executives at the company misrepresented or failed to timely disclose material and adverse information to investors.
  • Individuals with nonpublic information regarding the company should consider whether to assist our investigation or take advantage of the SEC Whistleblower program.

Reflex Advanced Materials Corp. Closes Second Tranche of Private Placement

Retrieved on: 
Wednesday, October 18, 2023

VANCOUVER, British Columbia, Oct. 18, 2023 (GLOBE NEWSWIRE) -- Reflex Advanced Materials Corp. (CSE:RFLX) (FSE:HF2) (“Reflex” or the “Company”) announces that, further to its news releases of September 22, 2023 and October 16, 2023, which announced a private placement offering of units of the Company of up to $1,000,000 (the “Offering”) and the closing of the first tranche of the Offering, respectively, it has closed the second tranche of the Offering (the “Second Tranche”) issuing 2,300,000 units of the Company (each, a “Unit”) at a price of $0.20 per Unit for aggregate gross proceeds of $460,000.

Key Points: 
  • In connection with closing of the Second Tranche, the Company paid cash finder’s fees in the aggregate of $36,800.00 and issued a total of 164,000 finder’s warrants (each, a “Finder’s Warrant”).
  • The net proceeds from the Second Tranche are intended to be used for general and administrative expenditures as well as non-flow-through exploration and evaluation expenditures.
  • In accordance with the listed issuer financing exemption under Part 5A of National Instrument 45-106 – Prospectus Exemptions, the Units issued in connection with the Second Tranche are not subject to a hold period pursuant to applicable Canadian securities laws.
  • This press release does not constitute an offer to acquire securities in any ‎jurisdiction.‎
    ON BEHALF OF THE BOARD OF DIRECTORS,

EVES ENERGY (SG): Significant Milestone in Sustainable Oil Production through Innovative Algae Technology & Team Expertise

Retrieved on: 
Thursday, October 19, 2023

This collaborative endeavour marks a pivotal moment in the journey towards sustainable oil production.

Key Points: 
  • This collaborative endeavour marks a pivotal moment in the journey towards sustainable oil production.
  • Over a year ago, discoveries unveiled in March 2022 ( http://bit.ly/3PW96OB ) paved the way for the development of a revolutionary technology for bulk microalgae oil production, which is on the brink of commercialization.
  • In parallel, EVES ENERGY is actively charting its course toward a Special Purpose Acquisition Company (SPAC) listing on NASDAQ, further solidifying its market position.
  • (Graphic: Business Wire)
    The groundbreaking technology carries immense potential to revolutionize conventional oil production methods while addressing critical sustainability challenges within the food industry.